Home › prevention
 

Keywords :   


Tag: prevention

FDA Approves Mercks Single-Dose EMEND (fosaprepitant dimeglumine) for Injection, in Combination with Other Antiemetic Agents, for the Prevention of Delayed Nausea and Vomiting in Adults Receiving Moderately Emetogenic Chemotherapy (MEC)

2016-02-04 14:00:00| Merck.com - Corporate News

Dateline City: KENILWORTH, N.J. First and Only Intravenous NK1 Receptor Antagonist Approved in the U.S. for Use in MEC KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for single-dose EMEND (fosaprepitant dimeglumine) for injection, Mercks substance P/neurokinin-1 (NK1) receptor antagonist, in combination with other antiemetic medicines, for the prevention of delayed nausea and vomiting in adults receiving initial and repeat courses of moderately emetogenic chemotherapy (MEC). Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558An Phan, 908-255-6325orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: combination agents receiving adults

 

Merck Announces FDA Acceptance of Biologics License Application for Bezlotoxumab, an Investigational Antitoxin for Prevention of Clostridium Difficile Infection Recurrence

2016-01-27 14:30:00| Merck.com - Corporate News

Dateline City: KENILWORTH, N.J. FDA Grants Priority Review with Target Action Date of July 23, 2016 Marketing Authorization Application Also Filed with the European Medicines Agency KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for bezlotoxumab, an investigational antitoxin for prevention of Clostridium difficile (C. difficile) infection recurrence. The FDA granted Priority Review for bezlotoxumab, with a Prescription Drug User Fee Act (PDUFA) action date of July 23, 2016. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Robert Consalvo, 908-236-1127orInvestors:Teri Loxam, 908-740-1986Amy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: application license acceptance prevention

 
 

Crime Prevention Program Summary

2015-12-21 20:42:40| PortlandOnline

Program summary document in the ONI Budget binders distributed to participants PDF Document, 58kbCategory: ONI Budget Orientation Handouts

Tags: program summary crime prevention

 

EPA Orders Surface Fire Prevention Measures at Bridgeton Landfill

2015-12-11 10:10:00| Waste Age

The federal environmental agency has taken action to control future damage at Missouri's infamous landfill. read more

Tags: orders fire surface measures

 

Social Media Firms Face Quandary Over Terror Prevention

2015-12-08 23:41:25| TechNewsWorld

Following the recent terrorist attacks in Paris and San Bernardino, Calif., social media companies are coming under increased pressure, both internally and externally, to protect their networks from being used as platforms for operational planning and propaganda. "We should build tools to help de-escalate tensions on social media," wrote Google Executive Chairman Eric Schmidt in an op-ed.

Tags: media social face prevention

 

Sites : [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] next »